Want to see FMFC full AI Analyst Report?
Kandal M Venture Limited Class A (FMFC) AI Stock Analysis
Kandal M Venture Limited Class A
(NASDAQ:FMFC)
The overall score is heavily pressured by extremely weak technicals and deteriorating operational cash flows, which signal significant near-term risk. The company's dramatically improved, debt-free balance sheet is a major positive, but it is not enough to offset the bearish momentum and declining profitability. The low P/E ratio offers a glimmer of value, but the lack of positive catalysts keeps the score low.
Kandal M Venture Limited Class A (FMFC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.41M
- Dividend Yield
- ―
- Average Volume (3M)
- 84.82K
- Price to Earnings (P/E)
- 4.3
- Beta (1Y)
- 1.44
- Revenue Growth
- -0.34%
- EPS Growth
- 12.39%
- Country
- US
- Employees
- 1,264
- Sector
- General
- Sector Strength
- 55
- Industry
- Personal Products & Services
Kandal M Venture Limited Class A Business Overview & Revenue Model
Company Description
Kandal M Venture Ltd. is a holding company, which engages in the manufacture of leather goods through its subsidiary. The firm's products include handbags, shoulder bags, crossbody bags, tote bags, backpacks, satchels, and wallets. It operates throug...
Kandal M Venture Limited Class A Financial Statement Overview
Summary
Financial performance is mixed. The balance sheet is exceptionally strong (Score 80) with near-zero debt and high equity, but this is offset by weak income (Score 30) due to declining margins and very poor cash flow (Score 20) which turned negative. The overall financial health is strained by operational inefficiencies despite a solid capital base.
Income Statement
30NegativeBalance Sheet
80PositiveCash Flow
20Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 17.13M | 17.13M | 17.19M | 13.97M | 13.47M |
| Gross Profit | 3.24M | 3.24M | 3.36M | 3.37M | 2.81M |
| EBITDA | 833.87K | 833.87K | 1.07M | 1.97M | 1.35M |
| Net Income | 235.63K | 235.63K | 209.67K | 1.12M | 744.50K |
Balance Sheet | |||||
| Total Assets | 11.21M | 11.21M | 10.07M | 10.18M | 5.89M |
| Cash, Cash Equivalents and Short-Term Investments | 3.58M | 3.58M | 102.70K | 235.35K | 361.47K |
| Total Debt | 87.63K | 87.63K | 5.26M | 7.43M | 1.12M |
| Total Liabilities | 3.16M | 3.16M | 9.69M | 10.01M | 6.84M |
| Stockholders Equity | 8.05M | 8.05M | 378.10K | 168.43K | -950.79K |
Cash Flow | |||||
| Free Cash Flow | -5.30M | -1.92M | 2.12M | 3.12M | 2.16M |
| Operating Cash Flow | -2.75M | -1.88M | 2.13M | 3.14M | 2.17M |
| Investing Cash Flow | -4.16M | -2.63M | -581.84K | -253.61K | -9,981 |
| Financing Cash Flow | 12.13M | 8.00M | -1.69M | -3.01M | -1.92M |
Kandal M Venture Limited Class A Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FMFC, the sentiment is Negative. The current price of 3.55 is below the 20-day moving average (MA) of 4.79, below the 50-day MA of 6.87, and below the 200-day MA of 12.48, indicating a bearish trend. The MACD of -1.01 indicates Positive momentum. The RSI at 27.34 is Positive, neither overbought nor oversold. The STOCH value of 14.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FMFC.
Kandal M Venture Limited Class A Risk Analysis
Kandal M Venture Limited Class A disclosed 57 risk factors in its most recent earnings report. Kandal M Venture Limited Class A reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksKandal M Venture Limited Class A Peers Comparison
Overall Rating
RGS58Neutral
MED47Neutral
FMFC45Neutral
MRM44Neutral
XWEL43Neutral
WW33Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 58Neutral | $74.17M | 10.75 | 3.66% | ― | 6.83% | -94.25% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 47Neutral | $135.87M | -3.29 | -21.13% | ― | -30.28% | -16409.29% | |
| 45Neutral | $1.66M | 4.31 | 2.94% | ― | -0.34% | 12.39% | |
| 44Neutral | $2.61M | -0.67 | -68.38% | ― | ― | ― | |
| 43Neutral | $6.88M | -0.13 | 317.52% | ― | -7.58% | -30.33% | |
| 33Underperform | $148.98M | -1.49 | -33.75% | ― | -11.63% | -108.59% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FMFC | Kandal M Venture Limited Class A | 3.38 | -40.22 | -92.25% | |
| MED | Medifast | 12.15 | 0.27 | 2.27% | |
| RGS | Regis Corporation | 29.67 | 0.17 | 0.56% | |
| XWEL | Xwell, Inc. | 0.69 | -0.20 | -22.47% | |
| MRM | Medirom Healthcare Technologies, Inc. | 0.33 | -1.59 | -82.81% | |
| WW | WW International, Inc. | 14.90 | -19.16 | -56.25% |
Kandal M Venture Limited Class A Corporate Events
Kandal M Venture Limited Warned by Nasdaq Over Public Float Deficiency
On October 15, 2026, Kandal M Venture Limited received a notice from Nasdaq that it no longer satisfies the exchange’s continued listing requirement to maintain at least 500,000 publicly held shares under Listing Rule 5550(a)(4). Nasdaq has giv...
Kandal M Venture Limited Posts Strong Interim Results on Productivity Gains and Global Expansion
Kandal M Venture Limited, a Nasdaq-listed contract manufacturer of affordable luxury leather goods with operations in China and Southeast Asia, reported a strong first half for the six months ended September 30, 2026. The company, which primarily pro...
Kandal M Venture Limited Enacts 1-for-40 Share Consolidation to Preserve Nasdaq Listing
Kandal M Venture Limited has approved a 1-for-40 consolidation of its Class A and Class B ordinary shares, reducing the number of outstanding shares while increasing their par value. The board approved the move on August 28, 2026, and shareholders fo...
Kandal M Venture Shareholders Approve 1-for-40 Share Consolidation at September 22 EGM
On September 22, 2026, Kandal M Venture Limited held an Extraordinary General Meeting of Shareholders in Hong Kong, where approximately 90.68% of exercisable votes as of the August 27 record date were represented in person or by proxy. Shareholders o...
Kandal M Venture Switches From Share Purchase to $2.5 Million Convertible Bond in Dumaine
On September 25, 2026, Kandal M Venture Limited terminated a previous sale and purchase agreement, originally entered on June 8, 2026, for the acquisition of a 15% stake in Dumaine International Ltd. by mutual consent with related parties Mr. Miao Du...
Kandal M Venture Limited Calls September EGM to Approve 40-for-1 Share Consolidation
On September 4, 2026, Kandal M Venture Limited reported to the U.S. Securities and Exchange Commission that it will convene an extraordinary general meeting of shareholders on September 22, 2026 in Hong Kong, with hybrid in-person and electronic part...
Kandal M Venture Limited Adds $750,000 Convertible Note and Signs Related-Party Deal LOIs on September 1, 2026
On September 1, 2026, Kandal M Venture Limited completed a third closing under its previously announced $25 million securities purchase agreement, issuing a $750,000 senior unsecured convertible promissory note maturing in 2029 at an initial conversi...
Kandal M Venture Limited Posts Steady FY2026 Results and Secures Growth Capital for Tech-Driven Expansion
Kandal M Venture Limited reported financial results on July 30, 2026, for its fiscal year ended March 31, 2026, showing essentially flat revenue at US$17.1 million, down 0.3% year over year, and a slight decline in gross margin to 18.9% as higher sta...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 22, 2026